InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has added a new agreement with a large regional health plan to its client list. According to the announcement, DRIO will deliver highly personalized digital health solutions to more than 160,000 plan members living with hypertension; the plan will launch this month. DRIO noted that its digital solution for hypertension, which is part of the company’s cardiometabolic product suite, was selected to engage the plan’s members with a highly personalized and consumer-centric approach to managing hypertension. “Dario’s proven ability to effectively drive outcomes-based engagement and deliver better results for our partners is a winning proposition for payers,” said DarioHealth president Rick Anderson in the press release. “We are excited to launch our new partnership with the plan this month and start engaging its members with highly personalized support to help improve hypertension outcomes.”

In addition, the company is also providing its preliminary second-quarter results as well as a business update. The report was for unaudited revenue results for the period ended June 30, 2023. According to the report, results for the three months were between $6 million and $6.15 million, and were driven by growth in DRIO’s business-to-business (“B2B”) sales channel, which has grown for the tenth quarter in a row. The company’s preliminary unaudited revenues for the six months ended June 30, 2023, were between $13 million and $13.15 million, resulting from the expected reduction in direct sales to consumers that took place during the same period. The report indicated that Dario had preliminary unaudited cash and cash equivalents of $52.6 million and that strategic partnerships are resulting in notable wins and contracts that are expected to contribute to revenue in 2023. In addition, a key milestone for the quarter was the on-schedule delivery of the private-labeled Aetna platform, which also represents additional revenue opportunities related to platform development in the second half of the year. “We believe that we are only beginning to realize the commercial potential of our strategic partners. MedOne and the Plan represent major wins for key strategic channel partners for Dario,” said DarioHealth CEO Erez Raphael in the press release. “We are excited to see our focus on the partner channel yield meaningful revenue as we continue to nurture these important relationships to help scale opportunities for Dario.”

To view the full press release, visit https://ibn.fm/cERYx

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.